{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:29:57Z","timestamp":1786994997704,"version":"build-2736575974"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071279"],"award-info":[{"award-number":["82071279"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.neuropharm.2025.110424","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T12:59:19Z","timestamp":1742389159000},"page":"110424","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["T-type calcium channels attenuate anxiety in MPTP-treated mice through modulating burst firing of dopaminergic neuron"],"prefix":"10.1016","volume":"272","author":[{"given":"Jihu","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengju","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suya","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shifei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2025.110424_bib1","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson's disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2025.110424_bib2","doi-asserted-by":"crossref","first-page":"15531","DOI":"10.1523\/JNEUROSCI.2961-09.2009","article-title":"Cellular mechanisms underlying burst firing in substantia nigra dopamine neurons","volume":"29","author":"Blythe","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110424_bib3","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/brain\/124.3.546","article-title":"Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey","volume":"124","author":"Boraud","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2025.110424_bib4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson's disease: diagnosis and management","volume":"5","author":"Chaudhuri","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2025.110424_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2023.102337","article-title":"Several neuropeptides involved in parkinsonian neuroprotection modulate the firing properties of nigral dopaminergic neurons","volume":"99","author":"Chen","year":"2023","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neuropharm.2025.110424_bib6","doi-asserted-by":"crossref","first-page":"11079","DOI":"10.1523\/JNEUROSCI.2713-04.2004","article-title":"Spontaneous opening of T-type Ca2+ channels contributes to the irregular firing of dopamine neurons in neonatal rats","volume":"24","author":"Cui","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110424_bib7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nature25752","article-title":"Astroglial Kir4.1 in the lateral habenula drives neuronal bursts in depression","volume":"554","author":"Cui","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2025.110424_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101263","article-title":"Oxidative stress and regulated cell death in Parkinson's disease","volume":"67","author":"Dion\u00edsio","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.neuropharm.2025.110424_bib9","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/s41467-022-28928-y","article-title":"Gq neuromodulation of BLA parvalbumin interneurons induces burst firing and mediates fear-associated network and behavioral state transition in mice","volume":"13","author":"Fu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2025.110424_bib10","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1523\/JNEUROSCI.04-11-02877.1984","article-title":"The control of firing pattern in nigral dopamine neurons: burst firing","volume":"4","author":"Grace","year":"1984","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110424_bib11","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1523\/JNEUROSCI.04-11-02866.1984","article-title":"The control of firing pattern in nigral dopamine neurons: single spike firing","volume":"4","author":"Grace","year":"1984","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110424_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911392","article-title":"NMDA receptor C-terminal domain signalling in development, maturity, and disease","volume":"23","author":"Haddow","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110424_bib13","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1085\/jgp.201812032","article-title":"Structure, function, and allosteric modulation of NMDA receptors","volume":"150","author":"Hansen","year":"2018","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.neuropharm.2025.110424_bib14","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1038\/s41467-022-29728-0","article-title":"Structure, gating, and pharmacology of human Ca(V)3.3 channel","volume":"13","author":"He","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2025.110424_bib15","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jagp.2023.09.001","article-title":"Anxiety change after dopamine therapy in Parkinson disease is independent of motor improvement","volume":"32","author":"Hinkle","year":"2024","journal-title":"Am. J. Geriatr. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110424_bib16","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41422-024-00959-8","article-title":"Structural basis for human Ca(v)3.2 inhibition by selective antagonists","volume":"34","author":"Huang","year":"2024","journal-title":"Cell Res."},{"key":"10.1016\/j.neuropharm.2025.110424_bib17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.tips.2008.10.004","article-title":"Regulation of neuronal T-type calcium channels","volume":"30","author":"Iftinca","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110424_bib18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","article-title":"Protocol for the MPTP mouse model of Parkinson's disease","volume":"2","author":"Jackson-Lewis","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuropharm.2025.110424_bib19","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson's disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110424_bib20","doi-asserted-by":"crossref","DOI":"10.1172\/JCI158742","article-title":"Thalamocortical circuits drive remifentanil-induced postoperative hyperalgesia","volume":"132","author":"Jin","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.neuropharm.2025.110424_bib21","doi-asserted-by":"crossref","first-page":"6327","DOI":"10.1113\/JP274565","article-title":"The role of T-type calcium channels in the subiculum: to burst or not to burst?","volume":"595","author":"Joksimovic","year":"2017","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2025.110424_bib22","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2025.110424_bib23","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejphar.2017.02.015","article-title":"Effects of iron overload, an iron chelator and a T-Type calcium channel blocker on cardiac mitochondrial biogenesis and mitochondrial dynamics in thalassemic mice","volume":"799","author":"Khamseekaew","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110424_bib24","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/epi.13710","article-title":"Carisbamate blockade of T-type voltage-gated calcium channels","volume":"58","author":"Kim","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2025.110424_bib25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12929-021-00781-z","article-title":"An electrophysiological perspective on Parkinson's disease: symptomatic pathogenesis and therapeutic approaches","volume":"28","author":"Lee","year":"2021","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.neuropharm.2025.110424_bib26","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/mds.26082","article-title":"Levodopa therapy for Parkinson's disease: pharmacokinetics and pharmacodynamics","volume":"30","author":"LeWitt","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuropharm.2025.110424_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.109946","article-title":"GLP-1 modulated the firing activity of nigral dopaminergic neurons in both normal and parkinsonian mice","volume":"252","author":"Liu","year":"2024","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110424_bib28","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13618","article-title":"Role of upregulation of the K(ATP) channel subunit SUR1 in dopaminergic neuron degeneration in Parkinson's disease","volume":"21","author":"Liu","year":"2022","journal-title":"Aging Cell"},{"key":"10.1016\/j.neuropharm.2025.110424_bib29","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/acn3.51735","article-title":"T-type calcium channels as therapeutic targets in essential tremor and Parkinson's disease","volume":"10","author":"Matthews","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.neuropharm.2025.110424_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23179894","article-title":"T-type calcium channels: a mixed blessing","volume":"23","author":"Melgari","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110424_bib31","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0024-3205(92)90479-9","article-title":"The electrophysiological actions of dopamine and dopaminergic drugs on neurons of the substantia nigra pars compacta and ventral tegmental area","volume":"51","author":"Mercuri","year":"1992","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2025.110424_bib32","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/jnc.14147","article-title":"Manganese- and 1-methyl-4-phenylpyridinium-induced neurotoxicity display differences in morphological, electrophysiological and genome-wide alterations: implications for idiopathic Parkinson's disease","volume":"143","author":"Mythri","year":"2017","journal-title":"J. Neurochem."},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2025.110424_bib33","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S1353-8020(09)70004-5","article-title":"L-dopa therapy for Parkinson's disease: past, present, and future","volume":"15","author":"Nagatsua","year":"2009","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.neuropharm.2025.110424_bib34","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1152\/physrev.00018.2002","article-title":"Molecular physiology of low-voltage-activated t-type calcium channels","volume":"83","author":"Perez-Reyes","year":"2003","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2025.110424_bib35","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1096\/fasebj.8.10.8050674","article-title":"Modulation of NMDA receptor function: implications for vertebrate neural development","volume":"8","author":"Scheetz","year":"1994","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2025.110424_bib36","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/nn.3185","article-title":"K-ATP channels in dopamine substantia nigra neurons control bursting and novelty-induced exploration","volume":"15","author":"Schiemann","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110424_bib37","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1038\/s41380-022-01513-x","article-title":"Cav3.1-driven bursting firing in ventromedial hypothalamic neurons exerts dual control of anxiety-like behavior and energy expenditure","volume":"27","author":"Shao","year":"2022","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110424_bib38","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.stemcr.2018.09.006","article-title":"T-Type calcium channels determine the vulnerability of dopaminergic neurons to mitochondrial stress in familial Parkinson disease","volume":"11","author":"Tabata","year":"2018","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.neuropharm.2025.110424_bib39","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.neubiorev.2021.11.044","article-title":"Subthalamic burst firing: a pathophysiological target in Parkinson's disease","volume":"132","author":"Tai","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2025.110424_bib40","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000364913","article-title":"Clinical implications of local field potentials for understanding and treating movement disorders","volume":"92","author":"Thompson","year":"2014","journal-title":"Stereotact. Funct. Neurosurg."},{"key":"10.1016\/j.neuropharm.2025.110424_bib41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41531-018-0067-z","article-title":"'Levodopa Phobia': a review of a not uncommon and consequential phenomenon","volume":"4","author":"Titova","year":"2018","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.neuropharm.2025.110424_bib42","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","article-title":"Challenges in the diagnosis of Parkinson's disease","volume":"20","author":"Tolosa","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2025.110424_bib43","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1474-4422(05)70285-4","article-title":"The diagnosis of Parkinson's disease","volume":"5","author":"Tolosa","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2025.110424_bib44","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.33549\/physiolres.932678","article-title":"Structure, function, and pharmacology of NMDA receptor channels","volume":"63","author":"Vyklicky","year":"2014","journal-title":"Physiol. Res."},{"key":"10.1016\/j.neuropharm.2025.110424_bib45","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.tins.2024.01.002","article-title":"Protein-protein interactions regulating \u03b1-synuclein pathology","volume":"47","author":"Wang","year":"2024","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110424_bib46","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12929-021-00779-7","article-title":"Dopamine, behavior, and addiction","volume":"28","author":"Wise","year":"2021","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.neuropharm.2025.110424_bib47","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1016\/j.cub.2014.09.046","article-title":"Burst firing synchronizes prefrontal and anterior cingulate cortex during attentional control","volume":"24","author":"Womelsdorf","year":"2014","journal-title":"Curr. Biol."},{"key":"10.1016\/j.neuropharm.2025.110424_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2017.01.011","article-title":"Pharmacological properties of SAK3, a novel T-type voltage-gated Ca(2+) channel enhancer","volume":"117","author":"Yabuki","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110424_bib49","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature25509","article-title":"Ketamine blocks bursting in the lateral habenula to rapidly relieve depression","volume":"554","author":"Yang","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2025.110424_bib50","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1126\/science.1167342","article-title":"Human substantia nigra neurons encode unexpected financial rewards","volume":"323","author":"Zaghloul","year":"2009","journal-title":"Science"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825001303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825001303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:59:08Z","timestamp":1762214348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390825001303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":50,"alternative-id":["S0028390825001303"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110424","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"T-type calcium channels attenuate anxiety in MPTP-treated mice through modulating burst firing of dopaminergic neuron","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110424","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110424"}}